Skip to main content
. 2021 Jul 28;9(1):10.1128/spectrum.00134-21. doi: 10.1128/spectrum.00134-21

FIG 1.

FIG 1

Assay specificity determination. (A) DBS and serum collected prior to December 2019 were tested using three lots of beads for DBS (A, B, C) and one bead lot for serum. *, P < 0.005 (B) Serum specimens containing antibodies to respiratory viruses, including other human coronaviruses, were tested. Lower line is cutoff for indeterminate results; upper line is cutoff for reactive results. MFI, median fluorescence intensity; N, nucleocapsid; S1, spike subunit 1.